DK1367061T3 - Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf - Google Patents
Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte herafInfo
- Publication number
- DK1367061T3 DK1367061T3 DK03291601T DK03291601T DK1367061T3 DK 1367061 T3 DK1367061 T3 DK 1367061T3 DK 03291601 T DK03291601 T DK 03291601T DK 03291601 T DK03291601 T DK 03291601T DK 1367061 T3 DK1367061 T3 DK 1367061T3
- Authority
- DK
- Denmark
- Prior art keywords
- perindopril
- synthesis
- pharmaceutically acceptable
- acceptable salts
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291601A EP1367061B1 (fr) | 2003-06-30 | 2003-06-30 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1367061T3 true DK1367061T3 (da) | 2006-05-15 |
Family
ID=29414888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03291601T DK1367061T3 (da) | 2003-06-30 | 2003-06-30 | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf |
Country Status (18)
Country | Link |
---|---|
US (1) | US7179833B2 (da) |
EP (1) | EP1367061B1 (da) |
JP (1) | JP4347341B2 (da) |
CN (1) | CN1802384B (da) |
AR (1) | AR044944A1 (da) |
AT (1) | ATE315043T1 (da) |
AU (1) | AU2004253721B2 (da) |
DE (1) | DE60303101T2 (da) |
DK (1) | DK1367061T3 (da) |
EA (1) | EA008836B1 (da) |
ES (1) | ES2256689T3 (da) |
HK (1) | HK1089188A1 (da) |
MY (1) | MY139159A (da) |
NZ (1) | NZ544003A (da) |
PL (1) | PL211161B1 (da) |
SI (1) | SI1367061T1 (da) |
WO (1) | WO2005003153A1 (da) |
ZA (1) | ZA200510330B (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1362864T3 (da) * | 2003-06-30 | 2007-09-17 | Servier Lab | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf |
ATE310012T1 (de) * | 2003-08-29 | 2005-12-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen |
SI21800A (sl) * | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
US7615571B2 (en) * | 2004-05-31 | 2009-11-10 | Ipca Laboratories Ltd. | Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt |
US9358318B2 (en) | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
US20060093655A1 (en) * | 2004-10-20 | 2006-05-04 | Lillian Bar | Method for making a reinforced absorbable multilayered hemostatic wound dressing |
DE602005009918D1 (de) | 2005-01-06 | 2008-11-06 | Ipca Lab Ltd | Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril |
US7291745B2 (en) | 2005-03-21 | 2007-11-06 | Glenmark Pharmaceuticals Limited | Process for the preparation of perindopril |
JP2008019214A (ja) * | 2006-07-13 | 2008-01-31 | Shiono Chemical Co Ltd | ペリンドプリルまたはその誘導体の製造方法 |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
SI9500140A (en) * | 1995-04-24 | 1996-10-31 | Genesis Para La Investigacion | Novel n-sulfoxy anhydrides, process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action |
ATE294814T1 (de) * | 2003-03-12 | 2005-05-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen |
US20050171165A1 (en) * | 2003-11-12 | 2005-08-04 | Bhirud Shekhar B. | Process for the preparation of perindopril |
-
2003
- 2003-06-30 AT AT03291601T patent/ATE315043T1/de active
- 2003-06-30 EP EP03291601A patent/EP1367061B1/fr not_active Expired - Lifetime
- 2003-06-30 DE DE60303101T patent/DE60303101T2/de not_active Expired - Lifetime
- 2003-06-30 ES ES03291601T patent/ES2256689T3/es not_active Expired - Lifetime
- 2003-06-30 DK DK03291601T patent/DK1367061T3/da active
- 2003-06-30 SI SI200330154T patent/SI1367061T1/sl unknown
-
2004
- 2004-06-28 PL PL380408A patent/PL211161B1/pl unknown
- 2004-06-28 EA EA200501925A patent/EA008836B1/ru not_active IP Right Cessation
- 2004-06-28 AU AU2004253721A patent/AU2004253721B2/en not_active Ceased
- 2004-06-28 US US10/562,490 patent/US7179833B2/en not_active Expired - Fee Related
- 2004-06-28 CN CN2004800160147A patent/CN1802384B/zh not_active Expired - Fee Related
- 2004-06-28 JP JP2006515295A patent/JP4347341B2/ja not_active Expired - Fee Related
- 2004-06-28 NZ NZ544003A patent/NZ544003A/en not_active IP Right Cessation
- 2004-06-28 ZA ZA200510330A patent/ZA200510330B/xx unknown
- 2004-06-28 WO PCT/FR2004/001637 patent/WO2005003153A1/fr active Application Filing
- 2004-06-28 MY MYPI20042540A patent/MY139159A/en unknown
- 2004-06-29 AR ARP040102277A patent/AR044944A1/es not_active Application Discontinuation
-
2006
- 2006-08-30 HK HK06109654.2A patent/HK1089188A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL211161B1 (pl) | 2012-04-30 |
SI1367061T1 (sl) | 2006-04-30 |
DE60303101T2 (de) | 2006-09-28 |
WO2005003153A1 (fr) | 2005-01-13 |
JP2007537974A (ja) | 2007-12-27 |
JP4347341B2 (ja) | 2009-10-21 |
EP1367061A1 (fr) | 2003-12-03 |
PL380408A1 (pl) | 2007-01-22 |
US20060178421A1 (en) | 2006-08-10 |
ZA200510330B (en) | 2007-05-30 |
EA008836B1 (ru) | 2007-08-31 |
AU2004253721A1 (en) | 2005-01-13 |
NZ544003A (en) | 2009-03-31 |
DE60303101D1 (de) | 2006-03-30 |
EA200501925A1 (ru) | 2006-06-30 |
CN1802384B (zh) | 2010-06-16 |
US7179833B2 (en) | 2007-02-20 |
MY139159A (en) | 2009-08-28 |
EP1367061B1 (fr) | 2006-01-04 |
AU2004253721B2 (en) | 2007-12-20 |
HK1089188A1 (en) | 2006-11-24 |
ATE315043T1 (de) | 2006-02-15 |
CN1802384A (zh) | 2006-07-12 |
ES2256689T3 (es) | 2006-07-16 |
AR044944A1 (es) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1268424T3 (da) | Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte | |
HK1089187A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
EG26629A (en) | A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts | |
DK1614687T3 (da) | Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf | |
HK1089188A1 (en) | Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof | |
HK1096409A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
DK1753720T3 (da) | Fremgangsmåde til fremstilling af perindopril og salte deraf | |
HK1096408A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
HK1095839A1 (en) | Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
DK1371659T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
DK1321471T3 (da) | Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf | |
DK1348684T3 (da) | Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril | |
DK1403275T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
DK1367063T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
HK1096407A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
DK1422236T3 (da) | Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf | |
DK1567524T3 (da) | Thia-epothilonderivater til behandling af cancer |